Login

Invest in the best early-stage technology companies before they become popular|Peter Livingston,Founder and General Partner,Unpopular Ventures 00:10:00

Share On Facebook Share On Twitter

Stanford Alumnus with 7+ years VC experience.

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
SiTime CEO Rajesh Vashist appears on CNBC's Mad Money.
00:10:00
Interim Report Update: Genova Property Group’s Performance and Future Outlook | Michael Moschewitz, CEO , Genova Property Group AB.
00:10:00
Developing next generation kinase inhibitors for autoimmune disease & cancer|Tim Mitchell, CEO, Sareum Holdings plc
00:10:00
Insights from Board Interview: Clarity's Founders, Healthcare, and Background |Dr Alan Taylor , Executive Chairma, Clarity Pharmaceuticals Ltd.
00:10:00
We invest in opportunities communities and people that are often overlooked|Marcos A. Rodriguez,CEO,Palladium Equity Partners
00:10:00
Marc Shaffer: Redefining Financial Stewardship at Searcy Financial Services
00:10:00
Third Quarter Market Shares Breakdown and Year-End Outlook | Morgan Christen, CEO, Spinnaker Investment Group, LLC.
00:10:00
"Expanding Opportunities in Commercial Lending: Dillon Freeman Joins LBC Capital’s San Diego Branch | Dillon Freeman - Managing Partner, LBC Capital"
00:10:00
Exploring Cameroon: Oriole Resources' Gold Exploration Efforts
00:10:00
Cerberus Partners with Volunteers of America to Support Education and Combat Homelessness
00:10:00
advice for open source founders|Astasia Myers, Founding Partner,Quiet Capital
00:10:00
address large-scale problems in human and environmental health|Gareth Asten,Managing Partner,Acre Venture Partners

© 2017 - Neuhu+